Literature DB >> 19403693

Obscurin interacts with a novel isoform of MyBP-C slow at the periphery of the sarcomeric M-band and regulates thick filament assembly.

Maegen A Ackermann1, Li-Yen R Hu, Amber L Bowman, Robert J Bloch, Aikaterini Kontrogianni-Konstantopoulos.   

Abstract

Obscurin is a multidomain protein composed of adhesion and signaling domains that plays key roles in the organization of contractile and membrane structures in striated muscles. Overexpression of the second immunoglobulin domain of obscurin (Ig2) in developing myotubes inhibits the assembly of A- and M-bands, but not Z-disks or I-bands. This effect is mediated by the direct interaction of the Ig2 domain of obscurin with a novel isoform of myosin binding protein-C slow (MyBP-C slow), corresponding to variant-1. Variant-1 contains all the structural motifs present in the known forms of MyBP-C slow, but it has a unique COOH terminus. Quantitative reverse transcription-polymerase chain reaction indicated that MyBP-C slow variant-1 is expressed in skeletal muscles both during development and at maturity. Immunolabeling of skeletal myofibers with antibodies to the unique COOH terminus of variant-1 demonstrated that, unlike other forms of MyBP-C slow that reside in the C-zones of A-bands, variant-1 preferentially concentrates around M-bands, where it codistributes with obscurin. Overexpression of the Ig2 domain of obscurin or reduction of expression of obscurin inhibited the integration of variant-1 into forming M-bands in skeletal myotubes. Collectively, our experiments identify a new ligand of obscurin at the M-band, MyBP-C slow variant-1 and suggest that their interaction contributes to the assembly of M- and A-bands.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19403693      PMCID: PMC2695803          DOI: 10.1091/mbc.e08-12-1251

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  56 in total

1.  Rapid response of cardiac obscurin gene cluster to aortic stenosis: differential activation of Rho-GEF and MLCK and involvement in hypertrophic growth.

Authors:  Andrei B Borisov; Maide O Raeker; Aikaterini Kontrogianni-Konstantopoulos; Kun Yang; David M Kurnit; Robert J Bloch; Mark W Russell
Journal:  Biochem Biophys Res Commun       Date:  2003-10-24       Impact factor: 3.575

2.  New aspects of obscurin in human striated muscles.

Authors:  Lena Carlsson; Ji-Guo Yu; Lars-Eric Thornell
Journal:  Histochem Cell Biol       Date:  2008-03-19       Impact factor: 4.304

3.  Obscurin targets ankyrin-B and protein phosphatase 2A to the cardiac M-line.

Authors:  Shane R Cunha; Peter J Mohler
Journal:  J Biol Chem       Date:  2008-09-09       Impact factor: 5.157

4.  The hydrophilic domain of small ankyrin-1 interacts with the two N-terminal immunoglobulin domains of titin.

Authors:  Aikaterini Kontrogianni-Konstantopoulos; Robert J Bloch
Journal:  J Biol Chem       Date:  2002-11-19       Impact factor: 5.157

5.  Interactions with titin and myomesin target obscurin and obscurin-like 1 to the M-band: implications for hereditary myopathies.

Authors:  Atsushi Fukuzawa; Stephan Lange; Mark Holt; Anna Vihola; Virginie Carmignac; Ana Ferreiro; Bjarne Udd; Mathias Gautel
Journal:  J Cell Sci       Date:  2008-05-13       Impact factor: 5.285

6.  A novel variant of cardiac myosin-binding protein-C that is unable to assemble into sarcomeres is expressed in the aged mouse atrium.

Authors:  Naruki Sato; Tsutomu Kawakami; Ayako Nakayama; Hiroyuki Suzuki; Hideko Kasahara; Takashi Obinata
Journal:  Mol Biol Cell       Date:  2003-06-13       Impact factor: 4.138

7.  Obscurin is a ligand for small ankyrin 1 in skeletal muscle.

Authors:  Aikaterini Kontrogianni-Konstantopoulos; Ellene M Jones; Damian B Van Rossum; Robert J Bloch
Journal:  Mol Biol Cell       Date:  2003-03       Impact factor: 4.138

8.  The NH2 terminus of titin spans the Z-disc: its interaction with a novel 19-kD ligand (T-cap) is required for sarcomeric integrity.

Authors:  C C Gregorio; K Trombitás; T Centner; B Kolmerer; G Stier; K Kunke; K Suzuki; F Obermayr; B Herrmann; H Granzier; H Sorimachi; S Labeit
Journal:  J Cell Biol       Date:  1998-11-16       Impact factor: 10.539

9.  The C-terminal IgI domains of myosin-binding proteins C and H (MyBP-C and MyBP-H) are both necessary and sufficient for the intracellular crosslinking of sarcomeric myosin in transfected non-muscle cells.

Authors:  Robert E Welikson; Donald A Fischman
Journal:  J Cell Sci       Date:  2002-09-01       Impact factor: 5.285

10.  Binding of an ankyrin-1 isoform to obscurin suggests a molecular link between the sarcoplasmic reticulum and myofibrils in striated muscles.

Authors:  Paola Bagnato; Virigina Barone; Emiliana Giacomello; Daniela Rossi; Vincenzo Sorrentino
Journal:  J Cell Biol       Date:  2003-01-13       Impact factor: 10.539

View more
  41 in total

Review 1.  Structure, interactions and function of the N-terminus of cardiac myosin binding protein C (MyBP-C): who does what, with what, and to whom?

Authors:  Mark Pfuhl; Mathias Gautel
Journal:  J Muscle Res Cell Motil       Date:  2012-04-20       Impact factor: 2.698

2.  Goodpasture antigen-binding protein (GPBP) directs myofibril formation: identification of intracellular downstream effector 130-kDa GPBP-interacting protein (GIP130).

Authors:  Francisco Revert-Ros; Ernesto López-Pascual; Froilán Granero-Moltó; Jesús Macías; Richard Breyer; Roy Zent; Billy G Hudson; Anas Saadeddin; Fernando Revert; Raül Blasco; Carmen Navarro; Deborah Burks; Juan Saus
Journal:  J Biol Chem       Date:  2011-08-09       Impact factor: 5.157

3.  Loss of actomyosin regulation in distal arthrogryposis myopathy due to mutant myosin binding protein-C slow.

Authors:  Maegen A Ackermann; Puja D Patel; Jane Valenti; Yasuharu Takagi; Earl Homsher; James R Sellers; Aikaterini Kontrogianni-Konstantopoulos
Journal:  FASEB J       Date:  2013-05-08       Impact factor: 5.191

4.  Myosin binding protein-C slow is a novel substrate for protein kinase A (PKA) and C (PKC) in skeletal muscle.

Authors:  Maegen A Ackermann; Aikaterini Kontrogianni-Konstantopoulos
Journal:  J Proteome Res       Date:  2011-09-22       Impact factor: 4.466

5.  Loss of giant obscurins promotes breast epithelial cell survival through apoptotic resistance.

Authors:  Nicole A Perry; Marey Shriver; Marie G Mameza; Bryan Grabias; Eric Balzer; Aikaterini Kontrogianni-Konstantopoulos
Journal:  FASEB J       Date:  2012-03-21       Impact factor: 5.191

6.  The kinase domains of obscurin interact with intercellular adhesion proteins.

Authors:  Li-Yen R Hu; Aikaterini Kontrogianni-Konstantopoulos
Journal:  FASEB J       Date:  2013-02-07       Impact factor: 5.191

7.  Molecular basis of the head-to-tail assembly of giant muscle proteins obscurin-like 1 and titin.

Authors:  Florian Sauer; Juha Vahokoski; Young-Hwa Song; Matthias Wilmanns
Journal:  EMBO Rep       Date:  2010-05-21       Impact factor: 8.807

Review 8.  Unraveling obscurins in heart disease.

Authors:  Alyssa Grogan; Aikaterini Kontrogianni-Konstantopoulos
Journal:  Pflugers Arch       Date:  2018-08-11       Impact factor: 3.657

Review 9.  Obscure functions: the location-function relationship of obscurins.

Authors:  Heather R Manring; Olivia A Carter; Maegen A Ackermann
Journal:  Biophys Rev       Date:  2017-03-29

Review 10.  Myosin binding protein-C slow: an intricate subfamily of proteins.

Authors:  Maegen A Ackermann; Aikaterini Kontrogianni-Konstantopoulos
Journal:  J Biomed Biotechnol       Date:  2010-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.